Today I purchased Arpril 70 puts in AstraZeneca. In the white-hot Biotech/Phrama one must choose whether to chase the stocks to the upside or hope for weight of gravity to bring laggards back to earth. AZN, in my opinion, has been flung up by all the maniacal merger activity happening all around it.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.